Get notified when HRL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsHormel posts 14% EPS gain despite $61M turkey sale loss; interim CEO and CFO in place
Filed May 28, 2026 · Period ending April 26, 2026 · Compared to 10-Q May 29, 2025 · ~1 min read
Key Changes
-
high
Adjusted EPS rose 14% to $0.40 in Q2 despite a $61M loss on the whole-bird turkey business sale, driven by improved turkey network performance and pricing actions across all segments.
MD&A: Earnings Performance verify on EDGAR → -
high
Both CEO and CFO roles now held by interim executives, signaling ongoing leadership transition following Q4 FY2025 restructuring and former CEO consulting agreement through April 2027.
Controls & Procedures verify on EDGAR → -
high
Portfolio reshaping continues: sold 51% of Justin's LLC in Q1 (gain) and whole-bird turkey business in Q2 (loss), while Q4 FY2025 restructuring targets admin cost reduction and workforce alignment.
MD&A: Divestitures & Restructuring verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade HRL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 29, 2026 · How we verify